IGC Pharma, Inc.
IGCNYSECIK 1326205HealthcareFiscal year ends Dec 31
Reports and events: 271 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2018-09-1216:32 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-18-001673 |
| 2018-08-0721:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-18-001360 |
| 2018-08-0320:24 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001185185-18-001341 |
| 2018-07-0620:19 ET | DEF 14A | Proxy statementPeriod 2018-08-06 | 0001185185-18-001222 |
| 2018-06-2117:18 ET | 10-K | Annual reportPeriod 2018-03-31 | 0001185185-18-001155 |
| 2018-05-1516:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001185185-18-000899 |
| 2018-05-0416:06 ET | 8-K | 8.01 Other events | 0001185185-18-000786 |
| 2018-04-1218:18 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001185185-18-000677 |
| 2018-03-1916:08 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001185185-18-000461 |
| 2018-03-0216:02 ET | 8-K | 8.01 Other events | 0001185185-18-000357 |
| 2018-02-2016:21 ET | 10-Q | Quarterly reportPeriod 2017-12-31 | 0001185185-18-000276 |
| 2018-01-0216:38 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-18-000005 |
| 2017-12-2219:39 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-17-002663 |
| 2017-12-1810:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-17-002626 |
| 2017-11-3021:14 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-17-002517 |
| 2017-11-2217:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-17-002479 |
| 2017-11-1717:03 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001185185-17-002428 |
| 2017-11-1314:24 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-17-002327 |
| 2017-10-1215:16 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001185185-17-002152 |
| 2017-10-1017:39 ET | DEF 14A | Proxy statementPeriod 2017-11-08 | 0001185185-17-002130 |
| 2017-09-2916:59 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001185185-17-002084 |
| 2017-08-1817:28 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001185185-17-001802 |
| 2017-07-1421:26 ET | 10-K | Annual reportPeriod 2017-03-31 | 0001185185-17-001544 |
| 2017-06-1209:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-17-001372 |
| 2017-05-2516:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-17-001264 |
| 2017-05-1219:56 ET | SC 13D | Ownership report, active investor | 0001185185-17-001114 |
| 2017-04-2508:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-17-000993 |
| 2017-04-2117:29 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001185185-17-000987 |
| 2017-04-0521:54 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001185185-17-000817 |
| 2017-04-0519:35 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001185185-17-000815 |
| 2017-02-2815:45 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001185185-17-000480 |
| 2017-02-2116:09 ET | 10-Q | Quarterly reportPeriod 2016-12-31 | 0001185185-17-000430 |
| 2017-02-1716:10 ET | 8-K | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001185185-17-000400 |
| 2017-01-0616:25 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001185185-17-000025 |
| 2016-11-2109:20 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001185185-16-005839 |
| 2016-11-2108:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001185185-16-005835 |
| 2016-08-1616:22 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0001185185-16-005260 |
| 2016-08-0417:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-16-005098 |
| 2016-07-1416:07 ET | 10-K | Annual reportPeriod 2016-03-31 | 0001185185-16-004982 |
| 2016-05-2017:20 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-16-004676 |
| 2016-04-0616:26 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-16-004175 |
| 2016-03-3018:11 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-16-004044 |
| 2016-03-1816:06 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-16-003940 |
| 2016-03-0910:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-16-003868 |
| 2016-03-0108:00 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-16-003804 |
| 2016-02-2917:00 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001185185-16-003794 |
| 2016-02-1616:23 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-16-003722 |
| 2016-02-1616:10 ET | 10-Q | Quarterly reportPeriod 2015-12-31 | 0001185185-16-003719 |
| 2015-11-1316:04 ET | 10-Q | Quarterly reportPeriod 2015-09-30 | 0001185185-15-002954 |
| 2015-08-2616:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001185185-15-002292 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.